Stay updated on MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.

Latest updates to the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check40 days agoChange Detected- Revision updated to v3.5.0 (replacing v3.4.3).SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.4.2 replaces the older Revision: v3.4.0 on the page, indicating a version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check90 days agoChange DetectedUI updates add a 'Show glossary' option and update QC-related fields (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with the revision updated to v3.4.0 (from v3.3.4).SummaryDifference0.1%

- Check104 days agoChange DetectedA minor revision banner update was made: Revision v3.3.4 was added and Revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.